1 Market Overview

1.1 Product Overview and Scope of Adipose Tissue-derived Stem Cell Therapy

1.2 Classification of Adipose Tissue-derived Stem Cell Therapy by Type

1.2.1 Overview: Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type in 2020

1.2.3 Autologous Stem Cells

1.2.4 Allogeneic Stem Cells

1.3 Global Adipose Tissue-derived Stem Cell Therapy Market by Application

1.3.1 Overview: Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Therapeutic Application

1.3.3 Research Application

1.4 Global Adipose Tissue-derived Stem Cell Therapy Market Size & Forecast

1.5 Global Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast by Region

1.5.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Region, (2016-2021)

1.5.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Adipose Tissue-derived Stem Cell Therapy Market Drivers

1.6.2 Adipose Tissue-derived Stem Cell Therapy Market Restraints

1.6.3 Adipose Tissue-derived Stem Cell Therapy Trends Analysis

2 Company Profiles

2.1 AlloCure

2.1.1 AlloCure Details

2.1.2 AlloCure Major Business

2.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.1.4 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AlloCure Recent Developments and Future Plans

2.2 Antria

2.2.1 Antria Details

2.2.2 Antria Major Business

2.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.2.4 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Antria Recent Developments and Future Plans

2.3 Celgene Corporation

2.3.1 Celgene Corporation Details

2.3.2 Celgene Corporation Major Business

2.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Celgene Corporation Recent Developments and Future Plans

2.4 Cellleris

2.4.1 Cellleris Details

2.4.2 Cellleris Major Business

2.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.4.4 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Cellleris Recent Developments and Future Plans

2.5 Corestem

2.5.1 Corestem Details

2.5.2 Corestem Major Business

2.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.5.4 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Corestem Recent Developments and Future Plans

2.6 Cytori Therapeutics

2.6.1 Cytori Therapeutics Details

2.6.2 Cytori Therapeutics Major Business

2.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.6.4 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Cytori Therapeutics Recent Developments and Future Plans

2.7 Intrexon

2.7.1 Intrexon Details

2.7.2 Intrexon Major Business

2.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.7.4 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Intrexon Recent Developments and Future Plans

2.8 Mesoblast

2.8.1 Mesoblast Details

2.8.2 Mesoblast Major Business

2.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.8.4 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Mesoblast Recent Developments and Future Plans

2.9 Pluristem Therapeutics

2.9.1 Pluristem Therapeutics Details

2.9.2 Pluristem Therapeutics Major Business

2.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.9.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Pluristem Therapeutics Recent Developments and Future Plans

2.10 Tissue Genesis

2.10.1 Tissue Genesis Details

2.10.2 Tissue Genesis Major Business

2.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.10.4 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Tissue Genesis Recent Developments and Future Plans

2.11 BioRestorative Therapies

2.11.1 BioRestorative Therapies Details

2.11.2 BioRestorative Therapies Major Business

2.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.11.4 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 BioRestorative Therapies Recent Developments and Future Plans

2.12 Celltex Therapeutics Corporation

2.12.1 Celltex Therapeutics Corporation Details

2.12.2 Celltex Therapeutics Corporation Major Business

2.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.12.4 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Celltex Therapeutics Corporation Recent Developments and Future Plans

2.13 iXCells Biotechnologies

2.13.1 iXCells Biotechnologies Details

2.13.2 iXCells Biotechnologies Major Business

2.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.13.4 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 iXCells Biotechnologies Recent Developments and Future Plans

2.14 Pluristem Therapeutics

2.14.1 Pluristem Therapeutics Details

2.14.2 Pluristem Therapeutics Major Business

2.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.14.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Pluristem Therapeutics Recent Developments and Future Plans

2.15 Cyagen

2.15.1 Cyagen Details

2.15.2 Cyagen Major Business

2.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.15.4 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Cyagen Recent Developments and Future Plans

2.16 Lonza

2.16.1 Lonza Details

2.16.2 Lonza Major Business

2.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Product and Solutions

2.16.4 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Lonza Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Adipose Tissue-derived Stem Cell Therapy Players Market Share

3.2.2 Top 10 Adipose Tissue-derived Stem Cell Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Adipose Tissue-derived Stem Cell Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application (2016-2021)

5.2 Adipose Tissue-derived Stem Cell Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2026)

6.2 North America Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2026)

6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Country

6.3.1 North America Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2026)

6.3.2 United States Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2026)

7.2 Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2026)

7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country

7.3.1 Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2026)

7.3.2 Germany Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

7.3.3 France Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Market Size by Region

8.3.1 Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Region (2016-2026)

8.3.2 China Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

8.3.5 India Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2026)

9.2 South America Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2026)

9.3 South America Adipose Tissue-derived Stem Cell Therapy Market Size by Country

9.3.1 South America Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Country

10.3.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Adipose Tissue-derived Stem Cell Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Adipose Tissue-derived Stem Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2021-2026)

Table 6. AlloCure Corporate Information, Head Office, and Major Competitors

Table 7. AlloCure Major Business

Table 8. AlloCure Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 9. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Antria Corporate Information, Head Office, and Major Competitors

Table 11. Antria Major Business

Table 12. Antria Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 13. Antria Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Celgene Corporation Corporate Information, Head Office, and Major Competitors

Table 15. Celgene Corporation Major Business

Table 16. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 17. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Cellleris Corporate Information, Head Office, and Major Competitors

Table 19. Cellleris Major Business

Table 20. Cellleris Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 21. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Corestem Corporate Information, Head Office, and Major Competitors

Table 23. Corestem Major Business

Table 24. Corestem Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 25. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Cytori Therapeutics Corporate Information, Head Office, and Major Competitors

Table 27. Cytori Therapeutics Major Business

Table 28. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 29. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Intrexon Corporate Information, Head Office, and Major Competitors

Table 31. Intrexon Major Business

Table 32. Intrexon Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 33. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Mesoblast Corporate Information, Head Office, and Major Competitors

Table 35. Mesoblast Major Business

Table 36. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 37. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Pluristem Therapeutics Corporate Information, Head Office, and Major Competitors

Table 39. Pluristem Therapeutics Major Business

Table 40. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 41. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Tissue Genesis Corporate Information, Head Office, and Major Competitors

Table 43. Tissue Genesis Major Business

Table 44. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 45. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. BioRestorative Therapies Corporate Information, Head Office, and Major Competitors

Table 47. BioRestorative Therapies Major Business

Table 48. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 49. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Celltex Therapeutics Corporation Corporate Information, Head Office, and Major Competitors

Table 51. Celltex Therapeutics Corporation Major Business

Table 52. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 53. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. iXCells Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 55. iXCells Biotechnologies Major Business

Table 56. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 57. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Pluristem Therapeutics Corporate Information, Head Office, and Major Competitors

Table 59. Pluristem Therapeutics Major Business

Table 60. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 61. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Cyagen Corporate Information, Head Office, and Major Competitors

Table 63. Cyagen Major Business

Table 64. Cyagen Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 65. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Lonza Corporate Information, Head Office, and Major Competitors

Table 67. Lonza Major Business

Table 68. Lonza Adipose Tissue-derived Stem Cell Therapy Product and Solutions

Table 69. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Global Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) by Players (2019-2021)

Table 71. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Players (2019-2021)

Table 72. Breakdown of Adipose Tissue-derived Stem Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Adipose Tissue-derived Stem Cell Therapy Players Head Office, Products and Services Provided

Table 74. Adipose Tissue-derived Stem Cell Therapy Mergers & Acquisitions in the Past Five Years

Table 75. Adipose Tissue-derived Stem Cell Therapy New Entrants and Expansion Plans

Table 76. Global Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) by Type (2016-2021)

Table 77. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Type (2016-2021)

Table 78. Global Adipose Tissue-derived Stem Cell Therapy Revenue Forecast by Type (2021-2026)

Table 79. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2021)

Table 80. Global Adipose Tissue-derived Stem Cell Therapy Revenue Forecast by Application (2021-2026)

Table 81. North America Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 82. North America Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 83. North America Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 84. North America Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 85. North America Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 86. North America Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)

Table 87. Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 88. Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 89. Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 90. Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 91. Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 92. Europe Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)

Table 93. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 94. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 95. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 96. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 97. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Region (2016-2021) & (USD Million)

Table 98. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue by Region (2021-2026) & (USD Million)

Table 99. South America Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 100. South America Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 101. South America Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 102. South America Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 103. South America Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 104. South America Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)

Table 105. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)

Table 106. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)

Table 107. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)

Table 108. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)

Table 109. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)

Table 110. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Adipose Tissue-derived Stem Cell Therapy Picture

Figure 2. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type in 2020

Figure 3. Autologous Stem Cells

Figure 4. Allogeneic Stem Cells

Figure 5. Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Application in 2020

Figure 6. Therapeutic Application Picture

Figure 7. Research Application Picture

Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 9. Global Adipose Tissue-derived Stem Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2016-2026)

Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region in 2020

Figure 12. North America Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 13. Europe Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. South America Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Adipose Tissue-derived Stem Cell Therapy Market Drivers

Figure 18. Adipose Tissue-derived Stem Cell Therapy Market Restraints

Figure 19. Adipose Tissue-derived Stem Cell Therapy Market Trends

Figure 20. AlloCure Recent Developments and Future Plans

Figure 21. Antria Recent Developments and Future Plans

Figure 22. Celgene Corporation Recent Developments and Future Plans

Figure 23. Cellleris Recent Developments and Future Plans

Figure 24. Corestem Recent Developments and Future Plans

Figure 25. Cytori Therapeutics Recent Developments and Future Plans

Figure 26. Intrexon Recent Developments and Future Plans

Figure 27. Mesoblast Recent Developments and Future Plans

Figure 28. Pluristem Therapeutics Recent Developments and Future Plans

Figure 29. Tissue Genesis Recent Developments and Future Plans

Figure 30. BioRestorative Therapies Recent Developments and Future Plans

Figure 31. Celltex Therapeutics Corporation Recent Developments and Future Plans

Figure 32. iXCells Biotechnologies Recent Developments and Future Plans

Figure 33. Pluristem Therapeutics Recent Developments and Future Plans

Figure 34. Cyagen Recent Developments and Future Plans

Figure 35. Lonza Recent Developments and Future Plans

Figure 36. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Players in 2020

Figure 37. Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Adipose Tissue-derived Stem Cell Therapy Revenue Market Share in 2020

Figure 39. Global Top 10 Players Adipose Tissue-derived Stem Cell Therapy Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Type in 2020

Figure 42. Global Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Type (2021-2026)

Figure 43. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Application in 2020

Figure 44. Global Adipose Tissue-derived Stem Cell Therapy Market Share Forecast by Application (2021-2026)

Figure 45. North America Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2016-2026)

Figure 46. North America Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2016-2026)

Figure 47. North America Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 48. United States Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2016-2026)

Figure 52. Europe Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2016-2026)

Figure 53. Europe Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 54. Germany Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Region (2016-2026)

Figure 62. China Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2016-2026)

Figure 69. South America Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2016-2026)

Figure 70. South America Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Adipose Tissue-derived Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source